Long-Term Outcomes of NSAID-Induced Small Intestinal Injury Assessed by Capsule Endoscopy in Korea: A Nationwide Multicenter Retrospective Study
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background/Aims: We evaluated the long-term outcome and clinical course of patients of nonsteroidal anti-inflammatory drug (NSAID)-induced small intestinal injury by performing capsule endoscopy (CE). Methods: A multicenter retrospective study was conducted using data collected from the CE nationwide database registry, which has been established since 2002. Results: A total of 140 patients (87 males; mean age, 60.6±14.8 years) from the CE nationwide database registry (n=2,885) were diagnosed with NSAID-induced small intestinal injury and enrolled in our study. Forty-nine patients (35.0%) presented with a history of aspirin use and an additional 49 (35.0%) were taking NSAIDs without aspirin. The most prominent findings after performing CE were multiple ulcerations (n=82, 58.6%) and erosions or aphthae (n=32, 22.9%). During the follow-up period (mean, 15.9±19.0 months; range, 0 to 106 months), NSAID-induced small intestinal injury only recurred in six patients (4.3%). Older age and hypertension were positive predictive factors for recurrence. Conclusions: These results suggest that the recurrence of NSAID-induced small bowel injury was not frequent in the presence of conservative treatment. Therefore, the initial diagnosis using CE and the medication history are important.
Abstract
Background/Aims: We evaluated the long-term outcome and clinical course of patients of nonsteroidal anti-inflammatory drug (NSAID)-induced small intestinal injury by performing capsule endoscopy (CE). Methods: A multicenter retrospective study was conducted using data collected from the CE nationwide database registry, which has been established since 2002. Results: A total of 140 patients (87 males; mean age, 60.6±14.8 years) from the CE nationwide database registry (n=2,885) were diagnosed with NSAID-induced small intestinal injury and enrolled in our study. Forty-nine patients (35.0%) presented with a history of aspirin use and an additional 49 (35.0%) were taking NSAIDs without aspirin. The most prominent findings after performing CE were multiple ulcerations (n=82, 58.6%) and erosions or aphthae (n=32, 22.9%). During the follow-up period (mean, 15.9±19.0 months; range, 0 to 106 months), NSAID-induced small intestinal injury only recurred in six patients (4.3%). Older age and hypertension were positive predictive factors for recurrence. Conclusions: These results suggest that the recurrence of NSAID-induced small bowel injury was not frequent in the presence of conservative treatment. Therefore, the initial diagnosis using CE and the medication history are important.
참고문헌 (20)
- Laine L, "Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient", Gastroenterology, 120, pp.594~606 (2001)
- Bjarnason I, "Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview", Gut, 30, pp.22~28 (1989)
- Hawkey CJ, "Non-steroidal anti-inflammatory drugs and peptic ulcers", BMJ, 300, pp.278~284 (1990)
- Kameda N, "A prospective, single-blind trial comparing wireless capsule endoscopy and double-balloon enteroscopy in patients with obscure gastrointestinal bleeding", J Gastroenterol, 43, pp.434~440 (2008)
- Yamamoto H, "Total enteroscopy with a nonsurgical steerable double-balloon method", Gastrointest Endosc, 53, pp.216~220 (2001)
- Sunada K, "Double-balloon endoscopy: past, present, and future", J Gastroenterol, 44, pp.1~12 (2009)
- Iddan G, "Wireless capsule endoscopy", Nature, 405, pp.417~ (2000)
- Rami E, "Capsule endoscopy: where are we at 2011 and where are we headed?", Intest Res, 10, pp.235~243 (2012)
- 임윤정, "Non-Steroidal Anti-Inflammatory Drug-Induced Enteropathy", Clinical Endoscopy, 45(2), pp.138~144 (2012), 대한소화기내시경학회
- Goldstein JL, "Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo", Clin Gastroenterol Hepatol, 3, pp.133~141 (2005)
- Graham DY, "Visible small-intestinal mucosal injury in chronic NSAID users", Clin Gastroenterol Hepatol, 3, pp.55~59 (2005)
- Kurokawa S, "A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and", or non-steroidal anti-inflammatory drug induced small bowel injury, 2014, pp.49, 239~244
- Watanabe T, "Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage", Dig Liver Dis, 45, pp.390~395 (2013)
- Matsumoto T, "Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study", Scand J Gastroenterol, 43, pp.490~496 (2008)
- Lanas A, "Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants", Am J Gastroenterol, 102, pp.507~515 (2007)
- Lanza FL, "Guidelines for prevention of NSAID-related ulcer complications", Am J Gastroenterol, 104, pp.728~738 (2009)
- Niwa Y, "Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study", J Gastroenterol, 43, pp.270~276 (2008)
- Wallace JL, "Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy", World J Gastroenterol, 19, pp.1861~1876 (2013)
- Wallace JL, "Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis", Gastroenterology, 141, pp.1314~1322 (2011)
- Watanabe T, "Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study", Clin Gastroenterol Hepatol, 6, pp.1279~1282 (2008)